|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2011-8-22
|
|
pubmed:abstractText |
Controversy about the relative performance of abacavir (ABC)/lamivudine (3TC) and tenofovir (TDF)/emtricitabine (FTC) in initial combination antiretroviral therapy (cART) exists.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adenine,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-HIV Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Deoxycytidine,
http://linkedlifedata.com/resource/pubmed/chemical/Dideoxynucleosides,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations,
http://linkedlifedata.com/resource/pubmed/chemical/Lamivudine,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphonic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/abacavir, lamivudine drug...,
http://linkedlifedata.com/resource/pubmed/chemical/emtricitabine,
http://linkedlifedata.com/resource/pubmed/chemical/tenofovir
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1944-7884
|
|
pubmed:author |
pubmed-author:CANOC Collaboration,
pubmed-author:ChanKeithK,
pubmed-author:CooperCurtisC,
pubmed-author:HoggRobert SRS,
pubmed-author:KleinMarina BMB,
pubmed-author:LoutfyMona RMR,
pubmed-author:MachoufNimaN,
pubmed-author:MontanerJulio S GJS,
pubmed-author:RaboudJanetJ,
pubmed-author:RourkeSean BSB,
pubmed-author:TanDarrell H SDH,
pubmed-author:TsoukasChrisC,
pubmed-author:WalmsleySharonS
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
58
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
38-46
|
|
pubmed:meshHeading |
pubmed-meshheading:21709570-Adenine,
pubmed-meshheading:21709570-Adult,
pubmed-meshheading:21709570-Anti-HIV Agents,
pubmed-meshheading:21709570-Canada,
pubmed-meshheading:21709570-Cohort Studies,
pubmed-meshheading:21709570-Deoxycytidine,
pubmed-meshheading:21709570-Dideoxynucleosides,
pubmed-meshheading:21709570-Drug Combinations,
pubmed-meshheading:21709570-Drug Substitution,
pubmed-meshheading:21709570-Female,
pubmed-meshheading:21709570-HIV Infections,
pubmed-meshheading:21709570-Humans,
pubmed-meshheading:21709570-Lamivudine,
pubmed-meshheading:21709570-Male,
pubmed-meshheading:21709570-Middle Aged,
pubmed-meshheading:21709570-Phosphonic Acids,
pubmed-meshheading:21709570-Retrospective Studies,
pubmed-meshheading:21709570-Treatment Failure,
pubmed-meshheading:21709570-Virus Replication
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Comparison of abacavir/lamivudine and tenofovir/emtricitabine among treatment-naive HIV-infected patients initiating therapy.
|
|
pubmed:affiliation |
Department of Medicine, University of Toronto, Ontario, Canada.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
